Anbieter: Studibuch, Stuttgart, Deutschland
hardcover. Zustand: Gut. 816 Seiten; 9783527341498.3 Gewicht in Gramm: 4.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 133,01
Anzahl: 1 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Zustand: New. Helga Ruebsamen-Schaeff, PhD, is founding CEO of AiCuris and the chair of AiCuris Scientific Advisory Board. Before founding AiCuris she served at Bayer as SVP and Head of Infectious Disease Research. Before that time, she was Scientific and Managing Direct.
Hardcover. Zustand: New.
Buch. Zustand: Neu. New Drug Development for Known and Emerging Viruses | Helga Rübsamen-Schaeff (u. a.) | Buch | Methods and Principles in Medicinal Chemistry | XXII | Englisch | 2021 | Wiley-VCH | EAN 9783527343379 | Verantwortliche Person für die EU: Wiley-VCH GmbH, Boschstr. 12, 69469 Weinheim, product-safety[at]wiley[dot]com | Anbieter: preigu.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 206,42
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 323 pages. 10.25x7.00x1.00 inches. In Stock.
Gebunden. Zustand: New. Alleyn Plowright, PhD, is Head of Integrated Drug Discovery Germany at Sanofi. He leads a cross-disciplinary research unit driving projects from target validation through to pre-clinical development. He has been instrumental in delivering a number of compou.
Zustand: New. Wolfgang Sippl, PhD, holds the chair in Medicinal Chemistry at the Institute of Pharmacy at the Martin Luther University of Halle-Wittenberg. Manfred Jung, PhD, is a full professor for Pharmaceutical Chemistry at the University of Freiburg and the co-chair.
Gebunden. Zustand: New. Norbert Handler holds a PhD in Medicinal Chemistry from the University of Vienna, where he worked for several years as a postdoc scientist in the field of Medicinal Chemistry. He received an Erwin-Schroedinger-Scholarship and moved to ETH Zuerich where he joi.
Anbieter: moluna, Greven, Deutschland
Zustand: New. Michael Gruss, owner and founder of Solid State Concepts, works as an independent scientific consultant for the pharmaceutical, chemical and nutrition industry. He earned a PhD in chemistry from Giessen University in 1998. In 2000, he joined Gruenenthal GmbH.
Buch. Zustand: Neu. Neuware - Discusses how to fight Ebola, SARS Corona, and other known or emerging human viruses by building on the successes in antiviral therapy of the past decades Written by leading medicinal chemists and virologists from academia and industry, this book discusses the entire field of antiviral drug discovery and development from a medicinal chemistry perspective, focusing on antiviral drugs, targets, and viral disease mechanisms. It provides an outlook on emerging pathogens such as Ebola, Zika, West Nile, Lassa, and includes a chapter on SARS Coronavirus-2 causing the present pandemic. 'New Drug Development for Known and Emerging Viruses' describes the discovery and development process of antiviral agents for different species of viruses and their targets based on the experiences from seven human viruses for which approved drugs are on the market (HIV, HCV, Influenza, RSV, HBV, HCMV, and HSV). It covers the properties and potential of currently approved antivirals, including combination drugs, and looks at novel antiviral strategies against emerging viruses. \* Covers the entire field of antiviral drug discovery and development \* Addresses the need for antiviral drugs to combat major health threats such as Ebola, Zika, West Nile, and SARS Coronavirus-2 \* Summarizes the successes of the past years in developing ground-breaking medicines against 7 major human viruses, both from the medicinal chemistry and the pharmacological angle \* Discusses practical and strategic challenges in the drug discovery and development process, including screening technologies, latency, and toxicity issues 'New Drug Development for Known and Emerging Viruses' is an important book for medicinal chemists, pharmaceutical chemists, virologists, and epidemiologists, and will be of great interest to those in the pharmaceutical industry and public health agencies.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 299,06
Anzahl: 1 verfügbar
In den WarenkorbZustand: New.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Gut. Gebraucht - Gut nur Teil 1! Ungeles. Mängelexpl., Lagerschaden (Knicke/Schmutz, Aufkleber) mögl., Büchersendung - (Verlag: Ralf Bünte).
Verlag: G.Braun, 1984
Anbieter: biblion2, Obersulm, Deutschland
Zustand: very good. Gebunden. Sofortversand aus Deutschland. Artikel wiegt maximal 500g. In Folie gebunden. Bibliotheksexemplar mit Stempel und Kleber. 87 Seiten.